New drug SLC-3010 takes on advanced solid tumors
Disease control
Terminated
This trial studies a new drug called SLC-3010, given alone or with chemotherapy (gemcitabine), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find safe doses and see if the drug can shrink tumors. The study is in two par…
Phase: PHASE1, PHASE2 • Sponsor: Selecxine • Aim: Disease control
Last updated Jul 03, 2026 20:17 UTC